Advocacy Actions

2023-07-14 > Beijing, Shanghai

Submission of the Comments on Fourth Batch National Volume-based Procurement of High-Value Medical Consumables Draft

The Healthcare Equipment Working Group submitted comments on the Fourth Batch National Volume-based Procurement of High-Value Medical Consumables draft. They suggested allowing industry enterprises to grow in the centralized procurement of sports medicine products, with tenders awarded to companies that achieve price reductions. It is important to establish clear rules with the involvement of companies and to consider the industry's requirements for innovation and development.

Read more
2023-07-14 > Beijing

Meeting with European Commission Trade Counsellor on Healthcare Equipment Working Group Issues

The Healthcare Equipment Working Group met with Helene Juramy, the trade counsellor from the Delegation of the European Commission to discuss public procurement and imported medical devices. Both parties expressed commitment to promoting fair trade practices in the healthcare equipment industry. Learn more about the meeting outcomes.

Read more
2023-07-14 > Beijing

Advocacy Letter Submitted Regarding Volume-Based Procurement of In Vitro Diagnostic Products in Anhui Province

The Consumable and Disposable Medical Device Desk has submitted an advocacy letter regarding the volume-based procurement of In Vitro Diagnostic products in Anhui Province. The letter addresses issues related to procurement policy alignment, elimination mechanisms, and limited price reduction space. Read on to learn more about the proposed solutions and recommendations for the implementation of volume-based procurement of IVD products in Anhui Province.

Read more
2023-07-13 > Beijing

Meeting with NIFDC and European Cosmetics Association

On 13th July 2023, Gerald Renner from Cosmetics Europe Association and Cosmetics Working Group representatives met with Mr. Lu Yong, vice president of NIFDC, Yang Zhen, deputy director of International Cooperation division, Wang Gangli, director of NIFDC, and Su Zhe, research assistance of NIFDC.

Read more
2023-07-13 > Beijing

Roundtable with the Institute of European Studies of Chinese Academy of Social Sciences and Beijing Municipal Commission of Development and Reform

On 13th July, the Institute of European Studies of Chinese Academy of Social Sciences and Beijing Municipal Commission of Development and Reform held a roundtable with the European Chamber and its member companies to understand the overview of European business in Beijing.

Read more
2023-07-13 > Beijing

European Chamber representatives meet with representatives from the Japan Bank for International Cooperation

On 13th July European Chamber representatives met with a visiting delegation from the Japan Bank for International Cooperation (JBIC).

Read more
2023-07-12 > Beijing

Meeting with Chairman of China Council for the Promotion of International Trade (CCPIT) Changsha Branch

On 12th July, the European Chamber representatives received the Chairman of China Council for the Promotion of International Trade (CCPIT) Changsha Branch at the Chamber Beijing office.

Read more
2023-07-11 > Beijing

Comments on the draft implementation regulation of the Carbon Border Adjustment Mechanism (CBAM) during its transitional period

On 11th July, the Carbon Market Sub-working Group and multiple Working Groups submitted comments to the European Commission on the draft implementation regulation of the Carbon Border Adjustment Mechanism (CBAM) during its transitional period.

Read more
2023-07-11 > Beijing

Meeting with Vice-Chairman of China Council for the Promotion of International Trade (CCPIT) Tianjin Sub-Council

On 11th July, the vice-chairman of China Council for the Promotion of International Trade (CCPIT) Tianjin Sub-Council visited the European Chamber Beijing Office and discussed with the Chamber representatives for the potential cooperation.

Read more
2023-07-10 > Beijing, Shanghai

Comments to National Healthcare Security Administration (NHSA) on the 2023 Renewal Rules for Negotiating Drugs

On 10th July, European Chamber Pharmaceutical Working Group submitted comments to National Healthcare Security Administration (NHSA) on the 2023 Renewal Rules for Negotiating Drugs.

Read more